mechanism of action glp-1 agonist Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms Cardiovascular Protection with a Long-Acting
Description
G., Snchez, E., Romero, I., Vidal-Puig, A., Berral, F
Final approval of the completed manuscript: C
[DOI] [PMC free article] [PubMed] [Google Scholar] 99.Castaneda D, et al
Since obesity is a major risk factor for both OA and diabetes, this has led to the exploration of GLP-1RA as a potential treatment for OA due to its weight loss and anti-inflammatory properties
